Chemokines: Key Players in Innate and Adaptive Immunity

Slides:



Advertisements
Similar presentations
Promoting Maturity Dec 2 Preview Generally speaking.
Advertisements

1 Circulating T cells Ag in the Inflammatory tissue Ch 9 T Cell-Mediated Immunity Ag-specific T cell response.
ORGANIZATION OF THE IMMUNE SYSTEM different cell types diffuse communication network between cells ‚signal transduction’ and inhibition similarity to the.
Chapter 10. Cell-mediated immunity (CMI) is the type of host defense that is mediated by T lymphocytes, and it serves as a defense mechanism against.
Rosacea as a Disease of Cathelicidins and Skin Innate Immunity
CATEGORY: CELLS DENDRITIC CELLS Dendritic Cells
Chemokines: Introduction
T Lymphocyte Transmigration
Kusumawadee Utispan, Sittichai Koontongkaew 
Road signs guiding leukocytes along the inflammation superhighway
HOMING
Volume 61, Issue 6, Pages (June 2002)
Microbial Symbiosis with the Innate Immune Defense System of the Skin
Roles for Chemokines in Liver Disease
Nat. Rev. Nephrol. doi: /nrneph
The Multitasking Organ: Recent Insights into Skin Immune Function
Mesenchymal Stromal Cells: Facilitators of Successful Transplantation?
Nat. Rev. Nephrol. doi: /nrneph
Histamine in the immune regulation of allergic inflammation
The 3 major types of innate and adaptive cell-mediated effector immunity  Francesco Annunziato, PhD, Chiara Romagnani, MD, PhD, Sergio Romagnani, MD  Journal.
The Multitasking Organ: Recent Insights into Skin Immune Function
Host Defence Peptides B cell
Jo-Ellen Murphy, Caroline Robert, Thomas S. Kupper 
Dietmar M.W. Zaiss, William C. Gause, Lisa C. Osborne, David Artis 
The Stromal Intervention: Regulation of Immunity and Inflammation at the Epithelial- Mesenchymal Barrier  Roni Nowarski, Ruaidhrí Jackson, Richard A. Flavell 
EGFR (Trans)activation Mediates IL-8 and Distinct Human Antimicrobial Peptide and Protein Production following Skin Injury  Amanda S. Büchau  Journal.
Innate Cells and T Helper 2 Cell Immunity in Airway Inflammation
Elia D. Tait Wojno, David Artis  Cell Host & Microbe 
Tilo Biedermann, Martin Röcken, José M. Carballido 
Epithelium: At the interface of innate and adaptive immune responses
Neuroregulator RET Initiates Peyer's-Patch Tissue Genesis
Innate Immunity: Ignored for Decades, but Not Forgotten
Figure 2 GM-CSF — a key player in inflammation and autoimmunity
Rosacea as a Disease of Cathelicidins and Skin Innate Immunity
Manipulated Microenvironment in Human Papilloma Virus–Infected Epithelial Cells: Is the CD40–CD154 Pathway Beneficial for Host or Virus?  Takatoshi Shimauchi,
CD8 T Cells and IFN-γ Emerge as Critical Players for Psoriasis in a Novel Model of Mouse Psoriasiform Skin Inflammation  Paola Di Meglio, João H. Duarte 
Nikhil Dhingra, Emma Guttman-Yassky 
Wenjun Ouyang, Jay K. Kolls, Yan Zheng  Immunity 
Tissue-Resident Memory T Cells
Mechanisms of Contact Sensitization Offer Insights into the Role of Barrier Defects vs. Intrinsic Immune Abnormalities as Drivers of Atopic Dermatitis 
Old Meets New: The Interaction Between Innate and Adaptive Immunity
Volume 37, Issue 1, Pages 5-7 (July 2012)
Chemokine Receptors in T-Cell-Mediated Diseases of the Skin
Skin-Resident T Cells: The Ups and Downs of On Site Immunity
Chemokines in the Biology of Lung Cancer
A Role for Th17 Cells in the Immunopathogenesis of Atopic Dermatitis?
Volume 31, Issue 5, Pages (November 2009)
Xue-Song Wu, Anke S. Lonsdorf, Sam T. Hwang 
A New “Immunological” Role for Adipocytes in Obesity
Revisiting the role of B cells in skin immune surveillance
HGF Guides T Cells into the Heart
Chemokines and the Tissue-Specific Migration of Lymphocytes
Rosacea: the Cytokine and Chemokine Network
Sam T. Hwang  Journal of Investigative Dermatology 
Anti-Cytokine Therapies in Response to Systemic Infection
Figure 4 Role of chemokines in dendritic cell migration
The Duality of Angiogenesis: Implications for Therapy of Human Disease
Mesenchymal Stromal Cells: Sensors and Switchers of Inflammation
Volume 71, Issue 12, Pages (June 2007)
Defining the Antigen Determinant for T-Cell-Mediated Contact Dermatitis Using p- Phenylenediamine: A Gateway to Chemical Immunology  Graham Elliott, Pranab.
John P. Sundberg, Lloyd E. King 
Cytokines and chemokines orchestrate atopic skin inflammation
Regulatory T Cells in Asthma
Sachin P. Gadani, James T. Walsh, John R. Lukens, Jonathan Kipnis 
Vaccines for Lung Cancer
Thymic stromal lymphopoietin and OX40 ligand pathway in the initiation of dendritic cell–mediated allergic inflammation  Yong-Jun Liu, MD, PhD  Journal.
Chemokines and allergic disease
Lymphatic vessels, inflammation, and immunity.
Molecular and cellular mechanisms of food allergy and food tolerance
Dietmar M.W. Zaiss, William C. Gause, Lisa C. Osborne, David Artis 
Presentation transcript:

Chemokines: Key Players in Innate and Adaptive Immunity Clemens Esche, Cristiana Stellato, Lisa A. Beck  Journal of Investigative Dermatology  Volume 125, Issue 4, Pages 615-628 (October 2005) DOI: 10.1111/j.0022-202X.2005.23841.x Copyright © 2005 The Society for Investigative Dermatology, Inc Terms and Conditions

Figure 1 The Role of Chemokines in the Innate and Adaptive Immune Responses in the Skin. Chemokines orchestrate effects that impact both innate and adaptive immune responses. Microbial invasion or injury (upper left) initiates innate immune pathways at least in part through TLR signaling. This results in the release of inflammatory cytokines and chemokines from both structural cells (epithelial and fibroblasts) and APC. These mediators are responsible for the activation of the endothelium (e.g., upregulation of adhesion molecules) and the recruitment and activation of leukocytes critical for innate immune responses (neutrophils, eosinophils, basophils, NK cells, monocytes, and immature DC/LC precursors). Several chemokines produced by keratinocytes are also thought to act as antimicrobial peptides (CCL20, CXCL9-11), directly killing microbes. Keratinocytes express several chemokine receptors (CCR3, CXCR1, and CXCR2) which likely play a role in the wound repair response (epithelial proliferation, and chemotaxis) and release chemokines important for angiogenesis following an innate insult. When resident, immature LC/DC are exposed to a danger signal (e.g., pathogen or injury) they mature resulting in a reduction in CCR6 and enhanced CCR7 expression. This releases the LC/DC from effects of the keratinocyte-derived CCR6 ligand (CCL20), and enables them to respond to the CCR7 ligand (CCL21), released by lymphatic vessels and promotes their migration to the draining LN. Maintenance of the normal LN architecture under homeostatic or inflammatory conditions is largely due to the directional effects of chemokines released by stromal cells of the lymph node. The CCR7 ligands (CCL19, CCL21) are responsible for the recruitment of naïve T cells to the T-zone and the CXCR5 ligand (CXCL13) is responsible for recruitment of B cells and T helper cells to the B cell follicle. The polarization of T helper cells into Th1 versus Th2 cells may be in part determined by the relative effects of CCR5 or CCR2 ligands, respectively. The trafficking of these memory cells back to the tissue sites is also under chemokine control with Th1 cells responding to CXCR3 ligands (CCL9-11) and CCR5 ligands (CCL3-5) and Th2 cells responding primarily to the CCR4 and CCR8 ligands (CCL1, CCL17 and CCL22). The specific recruitment of skin homing memory T cells, identified by the surface marker, CLA is under the influence of the CCR10 ligand (CCL27) in both Th1- and Th2-mediated skin diseases. In the case of atopic dermatitis (Th2 polarized), CCR4 ligands (CCL17 and CCL22) seem to be critical and in the case of psoriasis (Th1 polarized), the CCR6 ligand (CCL20) seems to be pivotal. There are several known mechanisms responsible for containing the inflammatory response initiated by inducible chemokines and include among other things; decoy receptors (DARC on RBC and endothelial cells, D6 on lymphatic endothelium) and tissue enzymes which can cleave and in some cases inactivate chemokines. Journal of Investigative Dermatology 2005 125, 615-628DOI: (10.1111/j.0022-202X.2005.23841.x) Copyright © 2005 The Society for Investigative Dermatology, Inc Terms and Conditions